Hydration in cancer patients.
Summary of "Hydration in cancer patients."
To provide an overview of issues central to hydration in an oncology population while highlighting recent advances and publications in the clinical and scientific literature. RECENT
Dehydration accounts for a significant number of unplanned visits to cancer clinics and emergency rooms. The decision to provide or withhold fluid in patients with terminal cancer is strongly influenced by subjective beliefs and the decision to use of hydration at the end of life should be individualized. Chronic dehydration may play a role in the pathogenesis of cancer.
Cancer patients are at high risk for dehydration from both the disease and the treatment. Treating physicians should have a low threshold for providing additional fluids to prevent dehydration. For patients at the end of life, hydration may be indicated in select patients.
Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
This article was published in the following journal.
Name: Current opinion in supportive and palliative care
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20693908
- DOI: http://dx.doi.org/10.1097/SPC.0b013e32833e48d1
To update medical professionals on the role of artificial hydration in terminally ill cancer patients and to highlight recent research.
Current hydration assessments methods are limited in cancer patients approaching death. Bioelectrical impedance analysis (BIA) is an accurate validated method of assessing body composition; however it...
Contrast-induced nephropathy (CIN) is a common cause of acute renal failure in hospital patients. To prevent CIN, identification and hydration of high-risk patients is important. Prevention of CIN by ...
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography.
Guidelines recommend saline hydration for prophylaxis of contrast-induced acute kidney injury (CI-AKI) in patients with chronic kidney disease (CKD) undergoing intravenous contrast media-enhanced CT (...
Introduction. Postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy operations still continue to be a serious problem. Intravenous fluid administration has been shown to reduce P...
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hydration with a saline solution may protect kidney cells from the s...
The goal of this clinical research study is to learn whether being hydrated (given liquids) through a catheter in a vein or in the tissue under the skin can improve symptoms of dehydration...
This is an observational study examining the workflow dynamics and training requirements that support effective use of subcutaneous hydration delivery (a newly FDA approved Baxter product)...
This study is being proposed with the objective to assess the potential benefits of induced diuresis by furosemide with matched hydration therapy compared to standard hydration in the prev...
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hydration with saline solution may protect kidney cells from the sid...
Medical and Biotech [MESH] Definitions
Institutions specializing in the care of cancer patients.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.
Nursing care provided cancer patients. It includes aspects of family functioning through education of both patient and family. The specialty of oncologic nursing focuses on cancer as a major health care problem.
Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.